Paul C.M. van den Berk

803 total citations
24 papers, 614 citations indexed

About

Paul C.M. van den Berk is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Paul C.M. van den Berk has authored 24 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 9 papers in Immunology and 8 papers in Oncology. Recurrent topics in Paul C.M. van den Berk's work include DNA Repair Mechanisms (16 papers), T-cell and B-cell Immunology (7 papers) and CRISPR and Genetic Engineering (5 papers). Paul C.M. van den Berk is often cited by papers focused on DNA Repair Mechanisms (16 papers), T-cell and B-cell Immunology (7 papers) and CRISPR and Genetic Engineering (5 papers). Paul C.M. van den Berk collaborates with scholars based in Netherlands, United States and Pakistan. Paul C.M. van den Berk's co-authors include Heinz Jacobs, Peter H.L. Krijger, Petra Langerak, Anders O.H. Nygren, Niek Wit, Niels de Wind, Jacob G. Jansen, Marc A. Hogenbirk, Bas Pilzecker and Cesare Lancini and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and The Journal of Experimental Medicine.

In The Last Decade

Paul C.M. van den Berk

23 papers receiving 611 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul C.M. van den Berk Netherlands	11	447	202	180	113	55	24	614
Joana Carvalho United Kingdom	11	356 0.8×	121 0.6×	207 1.1×	105 0.9×	42 0.8×	13	552
Katherine Yang‐Iott United States	12	346 0.8×	172 0.9×	146 0.8×	74 0.7×	19 0.3×	20	479
Elke Glasmacher Germany	12	426 1.0×	394 2.0×	128 0.7×	119 1.1×	22 0.4×	15	777
Annie De Smet France	10	530 1.2×	259 1.3×	100 0.6×	114 1.0×	19 0.3×	13	708
Chiara Vardabasso United States	9	740 1.7×	83 0.4×	159 0.9×	120 1.1×	44 0.8×	12	873
Deepak Perumal United States	14	529 1.2×	86 0.4×	209 1.2×	108 1.0×	106 1.9×	33	714
Fabio Mirabella United Kingdom	12	582 1.3×	69 0.3×	145 0.8×	119 1.1×	54 1.0×	16	762
Claudia Gordon United States	9	388 0.9×	241 1.2×	127 0.7×	47 0.4×	63 1.1×	13	598
Motoki Takaku United States	17	668 1.5×	110 0.5×	190 1.1×	144 1.3×	22 0.4×	34	882
Sabine Schreek Germany	9	459 1.0×	203 1.0×	239 1.3×	177 1.6×	36 0.7×	14	730

Countries citing papers authored by Paul C.M. van den Berk

Since Specialization

Citations

This map shows the geographic impact of Paul C.M. van den Berk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul C.M. van den Berk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul C.M. van den Berk more than expected).

Fields of papers citing papers by Paul C.M. van den Berk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul C.M. van den Berk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul C.M. van den Berk. The network helps show where Paul C.M. van den Berk may publish in the future.

Co-authorship network of co-authors of Paul C.M. van den Berk

This figure shows the co-authorship network connecting the top 25 collaborators of Paul C.M. van den Berk. A scholar is included among the top collaborators of Paul C.M. van den Berk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul C.M. van den Berk. Paul C.M. van den Berk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pilzecker, Bas, Aldo Spanjaard, Stefan Preković, et al.. (2023). Mammalian life depends on two distinct pathways of DNA damage tolerance. Proceedings of the National Academy of Sciences. 120(4). e2216055120–e2216055120. 4 indexed citations

Berk, Paul C.M. van den, Colin E.J. Pritchard, Ji‐Ying Song, et al.. (2023). A C57BL/6J Fancg-KO Mouse Model Generated by CRISPR/Cas9 Partially Captures the Human Phenotype. International Journal of Molecular Sciences. 24(13). 11129–11129.

Spanjaard, Aldo, Muhammad Assad Aslam, Paul C.M. van den Berk, et al.. (2023). Huwe1 supports B-cell development, B-cell-dependent immunity, somatic hypermutation and class switch recombination by regulating proliferation. Frontiers in Immunology. 13. 986863–986863. 2 indexed citations

Spanjaard, Aldo, Ben Morris, Cor Lieftink, et al.. (2022). Division of labor within the DNA damage tolerance system reveals non-epistatic and clinically actionable targets for precision cancer medicine. Nucleic Acids Research. 50(13). 7420–7435. 6 indexed citations

Pieters, Wietske, Mir Farshid Alemdehy, Muhammad Assad Aslam, et al.. (2021). The Widely Used Antihelmintic Drug Albendazole is a Potent Inducer of Loss of Heterozygosity. Frontiers in Pharmacology. 12. 596535–596535. 8 indexed citations

Aslam, Muhammad Assad, Mir Farshid Alemdehy, Bingtao Hao, et al.. (2020). The Ig heavy chain protein but not its message controls early B cell development. Proceedings of the National Academy of Sciences. 117(49). 31343–31352. 2 indexed citations

Pilzecker, Bas, Colin E.J. Pritchard, Olga Blomberg, et al.. (2016). PrimPol prevents APOBEC/AID family mediated DNA mutagenesis. Nucleic Acids Research. 44(10). 4734–4744. 38 indexed citations

Lancini, Cesare, Gaetano Gargiulo, Paul C.M. van den Berk, & Elisabetta Citterio. (2016). Quantitative analysis by next generation sequencing of hematopoietic stem and progenitor cells (LSK) and of splenic B cells transcriptomes from wild-type and Usp3-knockout mice. Data in Brief. 6. 556–561. 7 indexed citations

Wit, Niek, Paul C.M. van den Berk, Jacob G. Jansen, et al.. (2014). Roles of PCNA ubiquitination and TLS polymerases κ and η in the bypass of methyl methanesulfonate-induced DNA damage. Nucleic Acids Research. 43(1). 282–294. 40 indexed citations

10.

Lancini, Cesare, Paul C.M. van den Berk, Joseph H.A. Vissers, et al.. (2014). Tight regulation of ubiquitin-mediated DNA damage response by USP3 preserves the functional integrity of hematopoietic stem cells. The Journal of Cell Biology. 206(4). 2064OIA143–2064OIA143. 1 indexed citations

11.

Hogenbirk, Marc A., Marinus R. Heideman, Arno Velds, et al.. (2013). Differential Programming of B Cells in AID Deficient Mice. PLoS ONE. 8(7). e69815–e69815. 25 indexed citations

12.

Krijger, Peter H.L., Kyoo‐young Lee, Niek Wit, et al.. (2011). HLTF and SHPRH are not essential for PCNA polyubiquitination, survival and somatic hypermutation: Existence of an alternative E3 ligase. DNA repair. 10(4). 438–444. 52 indexed citations

13.

Krijger, Peter H.L., Paul C.M. van den Berk, Niek Wit, et al.. (2011). PCNA ubiquitination-independent activation of polymerase η during somatic hypermutation and DNA damage tolerance. DNA repair. 10(10). 1051–1059. 40 indexed citations

14.

Wit, Niek, Peter H.L. Krijger, Paul C.M. van den Berk, & Heinz Jacobs. (2011). Lysine Residue 185 of Rad1 Is a Topological but Not a Functional Counterpart of Lysine Residue 164 of PCNA. PLoS ONE. 6(1). e16669–e16669. 1 indexed citations

15.

Krijger, Peter H.L., Niek Wit, Paul C.M. van den Berk, & Heinz Jacobs. (2010). The Fanconi Anemia Core Complex Is Dispensable during Somatic Hypermutation and Class Switch Recombination. PLoS ONE. 5(12). e15236–e15236. 4 indexed citations

16.

Krijger, Peter H.L., Petra Langerak, Paul C.M. van den Berk, & Heinz Jacobs. (2009). Dependence of nucleotide substitutions on Ung2, Msh2, and PCNA-Ub during somatic hypermutation. The Journal of Experimental Medicine. 206(12). 2603–2611. 43 indexed citations

17.

Langerak, Petra, Anders O.H. Nygren, Peter H.L. Krijger, Paul C.M. van den Berk, & Heinz Jacobs. (2007). A/T mutagenesis in hypermutated immunoglobulin genes strongly depends on PCNAK164 modification. The Journal of Experimental Medicine. 204(8). 1989–1998. 125 indexed citations

18.

Luiten, Rosalie M., Esther W. M. Kueter, Wolter J. Mooi, et al.. (2005). Immunogenicity, Including Vitiligo, and Feasibility of Vaccination With AutologousGM-CSF–Transduced Tumor Cells in Metastatic Melanoma Patients. Journal of Clinical Oncology. 23(35). 8978–8991. 90 indexed citations

19.

Weijer, Kees, Paul C.M. van den Berk, Nuno Miranda, et al.. (1999). HGF/SF and its receptor c-MET play a minor role in the dissemination of human B-lymphoma cells in SCID mice. British Journal of Cancer. 81(1). 43–53. 7 indexed citations

20.

Hooijberg, Erik, Marjan J.W. Visseren, Paul C.M. van den Berk, et al.. (1996). Lysis of Syngeneic Tumor B Cells by Autoreactive Cytotoxic T Lymphocytes Specific for a CD 19 Antigen-Derived Synthetic Peptide. Journal of Immunotherapy. 19(5). 346–356. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact